# Fycompa Titration Intervals and Effects on Retention Rate

> **NCT03457129** · PHASE4 · COMPLETED · sponsor: **University of Arizona** · enrollment: 20 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Perampanel Oral Tablet

## Key facts

- **NCT ID:** NCT03457129
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-18
- **Primary completion:** 2021-02-24
- **Final completion:** 2021-12-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03457129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03457129, "Fycompa Titration Intervals and Effects on Retention Rate". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03457129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*